Five things for pharma marketers to know: Monday, May 15, 2023

FDA advisors voiced concerns about Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy.

Related Keywords

Elon Musk ,Adam Schiff ,Earl Francis Blumenauer ,Us Department Of Agriculture ,Drug Administration ,Reuters ,